Monobenzone Cream (Monobenzone) – Depigmentation Treatment for Vitiligo

Buy Monobenzone Cream from Tabexports – Global Pharmaceutical Supplier

Monobenzone Cream (Monobenzone) is a dermatological medication used for permanent depigmentation of normal skin in patients with extensive vitiligo. The active ingredient Monobenzone works by reducing melanin pigment in the skin, helping create a uniform skin tone in individuals with widespread depigmentation.

Tabexports supplies Monobenzone Cream for international pharmaceutical markets, offering bulk export, wholesale supply, and reliable worldwide delivery to the United States, United Kingdom, Australia, France, Thailand, and other global healthcare markets.

Active Ingredient

• Monobenzone

Monobenzone is a skin depigmenting agent that gradually destroys melanocytes, leading to the reduction of melanin production and resulting in lighter skin tone.

Medical Uses

✔ Treatment for extensive vitiligo
✔ Permanent skin depigmentation therapy
✔ Helps create even skin tone in severe vitiligo cases
✔ Dermatological treatment for pigment disorders

⚠ Should be used only under the supervision of a dermatologist.

Key Benefits

• Effective depigmentation therapy for vitiligo

• Helps achieve uniform skin color

• Widely used in dermatological treatment

• Suitable for patients with extensive vitiligo

• Clinically used skin pigment management therapy

Directions for Use

1. Clean and dry the affected area.

2. Apply a thin layer of Monobenzone Cream to pigmented areas.

3. Use once or twice daily as directed by a doctor.

4. Avoid sun exposure on treated skin.

Storage Instructions

• Store below 25°C

• Protect from sunlight and moisture

• Keep out of reach of children

Why Choose Tabexports?

🌍 Worldwide pharmaceutical exporter
📦 Bulk medicine supply for distributors and wholesalers
🚚 Reliable global shipping
🏭 High-quality pharmaceutical sourcing
📈 Trusted by pharmacies and healthcare suppliers worldwide

Tabexports exports Monobenzone Cream (Monobenzone) to USA, UK, Australia, France, Thailand, and global pharmaceutical markets.